IP Library Granted Patent US 9,095,570
Granted Patent B2
US 9,095,570 · App. 14/073,522 · Granted Aug 4, 2015

Lactoferrin and gut neuronal health in adults and/or elderly

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,570
App. No.
14/073,522
Granted
Aug 4, 2015
Kind
B2
Abstract

The present invention relates generally to the field of neuronal health and neuronal protection. One embodiment of the present invention relates to a composition that can be used for the protection of the enteric nervous system from neurodegeneration. Disorders linked to an impaired enteric nervous system can be treated or prevented by the administration of lactoferrin containing compositions according to the present invention.

Claims (6)

1. A method for the treatment of intestinal neuropathies and disorders associated therewith comprising administering a composition comprising an ingestible composition comprising lactoferrin in a concentration of at least 0.1 g/100 kcal of the composition to an elderly individual in need of same.

2. A method for the treatment of impairments of the enteric nervous system comprising administering a composition comprising an ingestible composition comprising lactoferrin in a concentration of at least 0.1 g/100 kcal of the composition to an elderly individual in need of same.

3. A method for the repair of the enteric nervous system comprising administering a composition comprising an ingestible composition comprising lactoferrin in a concentration of at least 0.1 g/100 kcal of the composition to an elderly individual in need of same.

4. The method of claim 3 , wherein the elderly individual has an intestinal neuropathy.

5. A method for the treatment of disorders linked to an impaired enteric nervous system comprising administering a composition comprising an ingestible composition comprising lactoferrin in a concentration of at least 0.1 g/100 kcal of the composition to an elderly individual in need of same.

6. The method of claim 5 , wherein the disorder is selected from the group consisting of a low digestive and absorptive capacity, malnutrition, gastrointestinal reflux, intestinal dismotility, a slow intestinal transit, constipation, chronic intestinal pseudoobstruction, fecal incontinence, a weak intestinal barrier function, enteral feeding intolerance, gut discomfort, and hard stools.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2014
From: FAURE, MAGALI; WANG, BING; SCHMITT, JEROEN
To: NESTEC S.A.
Reel/Frame 032042/0298 →